Salix Pharma (Nasdaq: SLXP) announced that Cipla Limited has granted Salix exclusive rights under certain patent applications in the “Rifaximin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE